The Effect of Glutamatergic Modulation on Cocaine Self-administration

Clinical trial NCT02596022 · COMPLETED

Trial details

NCT number: NCT02596022
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cocaine Dependence

Start date: 2013-06-01
Primary completion: 2015-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.